Top Markets
#1 Siren Siren +33.55%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.97%
#3 Ribbita by Virtuals Ribbita by Virtuals +18.33%
#4 Wiki Cat Wiki Cat +17.15%
#5 PulseChain PulseChain +16.92%
#6 Velvet Velvet +16.44%
#7 Cysic Cysic +16.42%
#8 Bitway Bitway +16.08%
#9 KUB Coin KUB Coin +15.73%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.35%
Coin of the day
Siren Siren
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
BLIS Technologies Limited BLIS Technologies Limited

BLIS Technologies Limited

BLT
Clasificación en acciones #31230
BLIS Technologies Limited, together with its subsidiaries, specializes in... BLIS Technologies Limited, together with its subsidiaries, specializes in creating and distributing health-focused products. These offerings are underpinned by unique bacterial strains that exhibit bacteriocin activity. The company prominently features several key probiotic strains: BLIS K12, a supplement engineered to bolster ear, nose, and throat well-being in young children, in addition to enhancing immune function and combating halitosis; BLIS M18, an oral probiotic designed to promote robust dental and gum health; and BLIS Q24, a probiotic formulation aimed at harmonizing and rejuvenating the skin's microbiome, thereby fostering healthier, clearer, and more radiant skin. Established in 2000, BLIS Technologies is based in Dunedin, New Zealand, and maintains a global presence with operations spanning New Zealand, the Asia Pacific region, Europe, the Middle East, Africa, and North America.
Precio por acción
$0.01084256
Capitalización bursátil
$13.87M
Cambio (1 día)
0.00%
Cambio (1 año)
1.70%
País
NZ
Comercio BLIS Technologies Limited (BLT)

Categoría

Healthcare
Ratio P/B de BLIS Technologies Limited (BLT)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de BLIS Technologies Limited, el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de BLIS Technologies Limited desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE